Anaesthetic Considerations for Rationalizing Drug Use in the Operating Theatre: Strategies in a Singapore Hospital During COVID-19
Abstract COVID-19 patients in the critical care unit tend to have prolonged hospital stay requiring high doses of sedation and paralysis to treat acute respiratory distress syndrome, resulting in a shortage of these drugs. In our hospital, we have instituted strategies to rationalise drug and oxygen usage. This includes prioritising time-sensitive elective cases, reducing overall elective case load, favouring opioid-reduction strategies and usage of alternative anaesthetic agents not commonly used in ICU. Both intensive care physicians and anaesthesiologists have to cooperate on drug conservation as similar drugs are used in elective operating lists as in the ICU. Patient safety is of utmost importance and we should keep in mind some pitfalls and ethical concerns of these alternative strategies..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:2 |
---|---|
Enthalten in: |
SN comprehensive clinical medicine - 2(2020), 7 vom: 12. Juni, Seite 871-873 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Au Yong, Phui Sze Angie [VerfasserIn] |
---|
Links: |
Volltext [lizenzpflichtig] |
---|
Themen: |
Anesthesia |
---|
doi: |
10.1007/s42399-020-00345-6 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
SPR040223574 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | SPR040223574 | ||
003 | DE-627 | ||
005 | 20230519162947.0 | ||
007 | cr uuu---uuuuu | ||
008 | 201007s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s42399-020-00345-6 |2 doi | |
035 | |a (DE-627)SPR040223574 | ||
035 | |a (SPR)s42399-020-00345-6-e | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q ASE |
082 | 0 | 4 | |a 610 |q ASE |
100 | 1 | |a Au Yong, Phui Sze Angie |e verfasserin |4 aut | |
245 | 1 | 0 | |a Anaesthetic Considerations for Rationalizing Drug Use in the Operating Theatre: Strategies in a Singapore Hospital During COVID-19 |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Abstract COVID-19 patients in the critical care unit tend to have prolonged hospital stay requiring high doses of sedation and paralysis to treat acute respiratory distress syndrome, resulting in a shortage of these drugs. In our hospital, we have instituted strategies to rationalise drug and oxygen usage. This includes prioritising time-sensitive elective cases, reducing overall elective case load, favouring opioid-reduction strategies and usage of alternative anaesthetic agents not commonly used in ICU. Both intensive care physicians and anaesthesiologists have to cooperate on drug conservation as similar drugs are used in elective operating lists as in the ICU. Patient safety is of utmost importance and we should keep in mind some pitfalls and ethical concerns of these alternative strategies. | ||
650 | 4 | |a SARS-CoV-2 |7 (dpeaa)DE-He213 | |
650 | 4 | |a COVID-19 |7 (dpeaa)DE-He213 | |
650 | 4 | |a Intensive Care |7 (dpeaa)DE-He213 | |
650 | 4 | |a Anesthesia |7 (dpeaa)DE-He213 | |
650 | 4 | |a Drug |7 (dpeaa)DE-He213 | |
650 | 4 | |a Rational Use |7 (dpeaa)DE-He213 | |
650 | 4 | |a Conservation |7 (dpeaa)DE-He213 | |
650 | 4 | |a Pandemic |7 (dpeaa)DE-He213 | |
700 | 1 | |a Kwa, Charlene Wen Xian |e verfasserin |4 aut | |
700 | 1 | |a Chan, Xin Hui Diana |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t SN comprehensive clinical medicine |d [Cham] : Springer International Publishing, 2019 |g 2(2020), 7 vom: 12. Juni, Seite 871-873 |w (DE-627)SPR038535785 |w (DE-600)2947252-0 |x 2523-8973 |7 nnns |
773 | 1 | 8 | |g volume:2 |g year:2020 |g number:7 |g day:12 |g month:06 |g pages:871-873 |
856 | 4 | 0 | |u https://dx.doi.org/10.1007/s42399-020-00345-6 |z lizenzpflichtig |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_SPRINGER | ||
912 | |a SSG-OLC-PHA | ||
951 | |a AR | ||
952 | |d 2 |j 2020 |e 7 |b 12 |c 06 |h 871-873 |